| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director, 10% Owner | Director
8 companies
Nelsen Robert is a Director, 10% Owner at LYEL with holdings across 8 companies. Recent SEC Form 4 filings include 9 buys and 15 sells.
Estimated insider holdings value: $415.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 1, 2025 | PRME Prime Medicine, Inc. | Director, 10% Owner | Buy | 3,030,300 | $3.30 | $9,999,990.00 | +94.7% | +7.7% | - | |
| Feb 15, 2024 | PRME Prime Medicine, Inc. | Director, 10% Owner | Buy | 3,200,000 | $6.25 | $20,000,000.00 | New | -13.3% | -63.6% | |
| Feb 8, 2024 | SANA Sana Biotechnology, Inc. | Director, 10% Owner | Buy | 1,818,181 | $5.50 | $9,999,995.50 | +5.4% | +54.1% | -51.5% | |
| Oct 24, 2022 | PRME Prime Medicine, Inc. | Director, 10% Owner | Buy | 800,000 | $17.00 | $13,600,000.00 | +7.0% | +10.1% | -54.9% | |
| Oct 16, 2019 | VIR Vir Biotechnology, Inc. | Director, 10% Owner | Buy | 1,000,000 | $20.00 | $20,000,000.00 | New | - | - | |
| Mar 6, 2017 | AGIO Agios Pharmaceuticals, Inc. | Director | Sell | 40,599 | $50.84 | $2,064,208.82 | -80.8% | - | - | |
| Feb 28, 2017 | AGIO Agios Pharmaceuticals, Inc. | Director | Sell | 243,082 | $49.36 | $11,997,895.83 | -30.1% | - | - | |
| Feb 23, 2017 | AGIO Agios Pharmaceuticals, Inc. | Director | Sell | 135,364 | $49.37 | $6,683,463.66 | -6.2% | - | - | |
| Jul 6, 2016 | SYRS Syros Pharmaceuticals, Inc. | Director, 10% Owner | Buy | 400,000 | $12.50 | $5,000,000.00 | +9.4% | - | - |